US Patent Issued to CRISPR THERAPEUTICS on March 4 for "Compositions and methods for differentiating stem cells into NK cells" (Massachusetts Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,241,087, issued on March 4, was assigned to CRISPR THERAPEUTICS AG (Zug, Switzerland).

"Compositions and methods for differentiating stem cells into NK cells" was invented by Viktoriia Kyrychenko (Cambridge, Mass.), Wai Lun Leung (Cambridge, Mass.) and Patrick Claudio Ovando Roche (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure features methods and compositions for differentiating stem cells into hematopoietic stem and progenitor cells (HSPC) and/or Natural Killer (NK) cells. The methods and compositions described herein are used to differentiate stem or progenitor cells having at least one gene-edit that is maintained in...